Pressor hyperreactivity to mental and hand-grip stresses in patients with hypercholesterolemia

Journal of Hypertension

Volumn 17, Issue 2, 1999, Pages 185-192

  Minami, Mayumi ^a   Atarashi, Keiichiro ^a   Ishiyama, Akihiro ^a   Hirata, Yasunobu ^a   Goto, Atsuo ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hypercholesterolemia; Intracellular Ca2+ concentration; Nitric oxide; Pressor hyperreactivity; Stress

Indexed keywords

CALCIUM; CYCLIC GMP; LOW DENSITY LIPOPROTEIN; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; BLOOD LEVEL; CALCIUM CELL LEVEL; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXERCISE; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MEAN ARTERIAL PRESSURE; MENTAL STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE;

EID: 0033047518     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917020-00002     Document Type: Article

References (44)

1. Stamler J, Westworth D, Neaton JD. Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Am J Med 1986; 80 (Suppl 2A):33-39.
2. Laurenzi M, Mancini M, Menotti A, Stamler J, Stamler R, Trevisan M, et al. on behalf of the Gubbio and Study Group. Multiple risk factors in hypertension: results from the Gubbio Study. J Hypertens 1990; 8 (Suppl 1):S7-S12.
3. Sachinidis A, Mengden T, Locher R, Brunner C, Vetter W. Novel cellular activities for low density lipoprotein in vascular smooth muscle cells. Hypertension 1990; 15:704-711.
4. Block LH, Knorr M, Vogt E, Locher R, Vetter W, Groscurth P, et al. Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci USA 1988; 85:885-889.
5. Chowienczyk PJ, Watts GF, Cockroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet 1992; 340:1430-1432.
6. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470-475.
7. Sullivan DR, Kruijswijk Z, West CE, Kohlmeier M, Katan MB. Determination of serum triglycerides by an enzymatic method not affected by free glycerol. Clin Chem 1985; 31:1227-1228.
8. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 2:583-595.
9. Friedewald WT, Levy RJ, Frederickson DS. Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem Acta 1972; 18:499-502.
10. Ohishi N, Ohkawa H, Miike A, Tatano T, Yagi K. A new method for lipid peroxides using a methylene blue derivative. Biochem Int 1985; 10:205-211.
11. Fotl A, Kimura S, DeQuattro V, Lee D. Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine. Clin Chem 1987; 33:2209-2213.
12. 2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium 1985; 6:145-157.
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260:3440-3450.
14. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-138.
15. Brooker G, Harper JF, Terasaki WL, Moylan RD. Radioimmunoassay for cyclic GMP and cyclic AMP. Adv Cyclic Nucleotide Res 1979; 10:1-33.
16. Hama N, Nakao K, Mukaiyama M, Kan S, Ogawa Y, Kawabata Y, el al. Fundamental and clinical evaluation of 'Shionoria ANP', human natriuretic peptide IRMA kit. Clin Rep 1991; 25:4205-4212.
17. Goode GK, Miller J, Heagerty AM. Hyperlipidemia, hypertension, and coronary diseases. Lancet 1995; 345:362-364.
18. Sung BH, Izzo JL Jr, Wilson MF. Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol. Am J Hypertens 1997; 10:592-599.
19. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:371-377.
20. Henry JP, Grim CE. Psychosocial mechanisms of primary hypertension. J Hypertens 1990; 8:783-793.
21. Grossman E, Oren S, Garavaglia GE, Schmieder R, Messerli FH. Disparate hemodynamic and sympathoadrenergic responses to isometric and mental stress in essential hypertension. Am J Cardiol 1989; 64:42-44.
22. Rostrup M, Westheim A, Kjeldsen SE, Eide I. Cardiovascular reactivity, coronary risk factors, and sympathetic activity in young men. Hypertension 1993; 22:891-899.
23. Brod J, Fencl V, Jirka J. Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arithmetic) in normotensive and hypertensive subjects. Clin Sci 1959; 18:269-279.
24. Julius S, Gudbrandsson T, Jamerson K, Shahab T. Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9:983-986.
25. Eliasson K, Hjemdahl P, Kahan T. Circulatory and sympathoadrenal responses to stress in borderline and established hypertension. J Hypertens 1983; 1:131-139.
26. Falkner B, Kushner H, Onesti G, Angelakos ET. Cardiovascular characteristics in adolescents who develop essential hypertension. Hypertension 1981; 3:521-527.
27. Sherwood A, Hinderliter AL, Light KC. Physiological determinants of exaggerated response to stress in borderline hypertension. Hypertension 1995; 25:384-390.
28. Böijersén A, Hamsten A, Eriksson M, Angelin B, Hjemdahl P. Platelet activity in vivo hyperlipoproleinemia: importance of combined hyperlipidemia. Thromb Haemost 1998; 79:268-275.
29. Falkner B, Onesti G, Angelakos ET, Fernandes M, Langman C. Cardiovascular response to mental stress in normal adolescents with hypertensive parents. Hypertension 1979; 1:23-30.
30. 2+-mobilization in platelets of healthy subjects and in patients with familial hyperlipidemia type II. Thromb Res 1991; 61:403-409.
31. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 1993; 92:652-662.
32. Egashira K, Hirooka K, Kai H, Sugimachi M, Suzuki S, Inou T, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89:2519-2524.
33. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338:1546-1550.
34. Kuo L, Davis MJ, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: restoration of endothelium-dependent responses by L-arginine. Circ Res 1992; 70:465-476.
35. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; ii:997-1000.
36. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349:837-842.
37. Rapoport RM, Murad F. Role of cyclic GMP in endothelium-dependent relaxation of vascular smooth muscle. In: Vanhoutte PM (editor): Relaxing and contracting factors. Clifton, NJ: Humana Press; 1988. pp. 219-239.
38. Galle J, Mulsch A, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb 1991; 11:198-203.
39. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992; 69:10-18.
40. Myers PR, Wright TF, Tanner MA, Ostlund RE. The effects of LDL on EDRF bioactivity and nitric oxide production in vascular endothelium. J Lab Clin Med 1994; 124:672-683.
41. Minor RL Jr, Myers PR, Guerra R Jr, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990; 86:2109-2116.
42. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-led rabbits. Circ Res 1991; 69:1293-1300.
43. Inoue N, Hirata K, Yamada M, Hamamori Y, Matsuda Y, Akita H, et al. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial celd phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ Res 1992; 71:1410-1421.
44. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 1991; 43:109-142.